[Clinical results of rokitamycin dry syrup on respiratory tract infections in pediatric field].
1. A total of 15 patients with pediatric respiratory tract infections were mediated with rokitamycin (RKM) dry syrup, and its clinical effects were excellent in 2, good in 10, fair in 1 and poor in 1. 2. The efficacy rate in Streptococcus pneumoniae pneumonia and mycoplasmal pneumonia was 100%. 3. Clinical effects on 7 patients with Haemophilus influenzae were excellent in 1, good in 4, fair in 1 and poor in 1. 4. No adverse reaction was observed, and the taste and odor of RKM was well accepted by the children. 5. RKM is useful and one of the first choice antibiotics on respiratory tract infections in pediatric field.
Saito
A
A
Department of Pediatrics, Aomori Prefectural Central Hospital.
Watanabe
A
A
D002648:Child; D004352:Drug Resistance, Microbial; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007933:Leucomycins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D015644:Miocamycin / Q000031:analogs & derivatives*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000187:drug effects
D007933:Leucomycins; D015644:Miocamycin; C033383:rokitamycin